In summary, we found that low mRNA expression of SGPP1 and PLPP3 correlates with worse prognosis in patients with BC, particularly in those with TNBC, and that high expression of both of these genes may promote the infiltration of immune cells, especially DCs, into the tumor microenvironment (Supplementary Figure S14). This evidence concerns the gene PLPP3 and breast cancer.